June Almenoff - Nov 1, 2024 Form 3 Insider Report for Actinium Pharmaceuticals, Inc. (ATNM)

Role
Director
Signature
/s/ June Almenoff
Stock symbol
ATNM
Transactions as of
Nov 1, 2024
Transactions value $
$0
Form type
3
Date filed
11/5/2024, 05:10 PM
Previous filing
Aug 14, 2024

No securities are beneficially owned.